Kathy Jo Fahey, VP of Regulatory & Clinical at Nuvectra Corp (NVTR), sold 93 shares at $5.36 ($498) on 2017-01-04, disclosed to the SEC on 2017-01-04.
Open-market sale of $498 NVTR by VP of Regulatory & Clinical. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.